Safety and Efficacy of the Transfusion of UCB in Patients With an ASD Depending on the Degree of HLA Compatibility. (ASD-HLA2019)
Protocol for Evaluating the Safety and Efficacy of Transfusion of Umbilical Cord Blood in Patients With a Diagnosis of Autism Spectrum Disorder Depending on the Degree of Tissue Compatibility of the Donor and the Recipient
Sponsor: INBIO, LLC
A PHASE1/PHASE2 clinical study on Autism and Autism Spectrum Disorder, this trial is ongoing. The trial is conducted by INBIO, LLC and has accumulated 9 data snapshots since 2019. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE1/PHASE2
-
Feb 2025 — Sep 2025 [monthly]
Unknown PHASE1/PHASE2
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Feb 2023 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
Status: Unknown Status → Recruiting
▶ Show 4 earlier versions
-
Jul 2022 — Feb 2023 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Jan 2021 — Jul 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2019 — Apr 2020 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Aug 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- INBIO, LLC
- State-Financed Health Facility Samara Regional Medical Center Dinasty
For direct contact, visit the study record on ClinicalTrials.gov .